4
Changes in Ownership
Ernexa Therapeutics Inc. Filed Acc 0001493152-20-024073
CEO gave up 170 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Wolff Allen · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-19 | Shares withheld for taxes : show line 1 in the form | −170 | $2.17 | $369 | 141,865 | D |
Loading xslF345X03/ownership.xml…